hrmy: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash used in financing activities	-6,034	-3,038
Net increase in cash, cash equivalents, and restricted cash	193,998	93,049
Cash and cash equivalents at beginning of period	453,271	-
Cash and cash equivalents at end of period	647,269	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash used in financing activities	-6,034	-3,038
Net increase in cash, cash equivalents, and restricted cash	193,998	93,049
Cash and cash equivalents at beginning of period	453,271	-
Cash and cash equivalents at end of period	647,269	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Harmony Biosciences Holdings, Inc. (HRMY)